BioCentury
ARTICLE | Company News

Esperion acquires Talaria for $7.3 million

October 5, 2000 7:00 AM UTC

ESPR acquired Talaria (Boston, Mass.) for 813,000 shares valued at $9 a share, for a total of $7.3 million. The deal will give ESPR access to Talaria's LUV (large unilamellar vessel) technology for tr...